Specialty pharmacy is a big area of growth, with opportunity for patients, and specialty pharmacists can help payers and insurers ensure that patients get the full value of oncology medications, noted Andre Harvin, PharmD, MS, MBA, chief pharmacy officer, Oncology Services, Cone Health Cancer Centers.
Specialty pharmacy is a big area of growth, with opportunity for patients, and specialty pharmacists can help payers and insurers ensure that patients get the full value of oncology medications, some of which are 6 figures in terms of their annual costs, noted Andre Harvin, PharmD, MS, MBA, chief pharmacy officer, Oncology Services, Cone Health Cancer Centers.
Transcript
What are some optimal strategies to incorporating a specialty pharmacy team into oncology care that can optimize outcomes?
Specialty pharmacies, when we start talking about those more expensive oral oncology medications that continue to come to the market, these are game-changers. There's really no other way to say it. With a specialty pharmacy before, when a patient maybe had to have a toxic antineoplastic medication that they had to come in multiple days for an infusion, now we have options to send them out of a clinic with an oral medication. Some of them can be taken daily, some of them maybe have a little bit more of a rigorous schedule on it, but now they don't have to come back and have an IV tied to their arm; they can take this oral medication and have similar or sometimes even better outcomes.
The really great thing about that is that, if you're not doing specialty pharmacy, then the question is, why not? It's such a big area of growth; it's such an opportunity not only for your patients, but also because this is a business summit, there's a huge business behind it as well that is exceptionally profitable. And so the great thing about it is that you want a highly trained individual that is a specialist in those medications to be able to talk to that patient about it. When these new medications that are coming out are 6 figures in terms of their annual costs, and some of them over a quarter million dollars for their annual costs, as a provider—and you have to think about [the] other side as a payer, as an insurer—you want to ensure that the patients are getting the full value out of that.
What better way than to have a highly specialized, highly trained individual like a pharmacist to help them on that journey? So, specialty pharmacists, they reach out to the patients on normal intervals before they do any refills. They make sure they ask critical questions about how many pills they have left, if they've had any difficulties. They can help manage side effects before a patient may make a decision not to continue taking the medication, which we see sometimes. Your specialty pharmacist can not only ensure that your patients are going to adhere to their drug—therefore, having a higher chance of getting that clinical outcome—but they're also going to make sure that we're getting the full value out of that medication and that we prevent a patient from stopping that drug prematurely.
So there's only benefits, I would say, from having a specialty pharmacist as part of your program. They are a little bit difficult to stand up, but once you get it up and running, you'll see the value immediately.
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More